Literature DB >> 28910681

The imaging spectrum of posterior reversible encephalopathy syndrome: A pictorial review.

Emily Brady1, Neal S Parikh2, Babak B Navi2, Ajay Gupta3, Andrew D Schweitzer4.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is characterized by the acute onset of neurologic symptoms (headache, altered mental status, visual changes, seizures) with accompanying vasogenic edema on brain imaging. Risk factors for PRES include infection, uremia, malignancy, autoimmune disorders, the peripartum state and hypertension. PRES is classically described as being posterior (i.e. parieto-occipital) but radiologic variants are increasingly recognized. This pictorial review demonstrates the heterogeneity of the different radiologic presentations of PRES in reference to lesion distribution, hemorrhage, diffusion restriction, contrast enhancement, and other associated findings.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diffusion restriction; Hemorrhage; MRI; PRES; Posterior reversible encephalopathy syndrome; Vasogenic edema

Mesh:

Year:  2017        PMID: 28910681     DOI: 10.1016/j.clinimag.2017.08.008

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  13 in total

Review 1.  [MRI alterations in immunomodulation].

Authors:  K Guggenberger; H Urbach
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

Review 2.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

3.  Posterior reversible encephalopathy syndrome due to hypercalcaemia: a rare cause.

Authors:  Nandakrishna Bolanthakodi; Sudha Vidyasagar; Muralidhar Varma; Avinash Holla
Journal:  BMJ Case Rep       Date:  2019-02-11

4.  Late-onset Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like Episodes (MELAS) Syndrome in a 63-year-old Patient.

Authors:  Hassan Abdullah; Syed Shah; Humza Husain; Furqan Hassan; Hamza Maqsood
Journal:  Cureus       Date:  2020-04-27

5.  Spinal cord involvement in posterior reversible encephalopathy syndrome without brain hemisphere vasogenic alterations: a case report.

Authors:  Umberto Magliola; Luisa Lobetti Bodoni; Giuseppina Glioti; Alessandro Balducci; Gabriella Paglia
Journal:  Acta Neurol Belg       Date:  2022-03-24       Impact factor: 2.396

6.  Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report.

Authors:  Tim Sinnecker; Michaela Andelova; Michael Mayr; Stephan Rüegg; Michael Sinnreich; Juergen Hench; Stephan Frank; André Schaller; Christoph Stippich; Jens Wuerfel; Leo H Bonati
Journal:  BMC Neurol       Date:  2019-05-08       Impact factor: 2.474

7.  Unilateral posterior reversible encephalopathy syndrome characterized with a long and gradually exacerbating course over 3 years and that presented propofol infusion syndrome - A case report.

Authors:  Masahito Katsuki; Dan Ozaki; Norio Narita; Naoya Ishida; Ohmi Watanabe; Siqi Cai; Shinya Shimabukuro; Teiji Tominaga
Journal:  Surg Neurol Int       Date:  2021-01-13

8.  Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model.

Authors:  Knut Asbjørn Rise Langlo; Gustavo Jose Justo Silva; Tina Syvertsen Overrein; Volker Adams; Ulrik Wisløff; Håvard Dalen; Natale Rolim; Stein Ivar Hallan
Journal:  Front Cardiovasc Med       Date:  2021-02-12

9.  Clinical, Etiological and Imaging Profile of Posterior Reversible Encephalopathy Syndrome: A Prospective and Follow-Up Study.

Authors:  Saurabh Bansal; Ramandeep Bansal; Manoj Kumar Goyal; Aastha Takkar; Ramandeep Singh; Paramjeet Singh; Vivek Lal
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383

10.  Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size.

Authors:  Kunhua Li; Yang Yang; Dajing Guo; Dong Sun; Chuanming Li
Journal:  Front Neurol       Date:  2020-03-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.